A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer

Abstract

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 3 subjects at WCMC. An additional 12 subjects enrolled (7 treated) at participating sub-sites. Reports submitted to WCMC DSMB with recommendation to proceed with enrollment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2011
Accession Number
ADA553447

Entities

People

  • Scott T Tagawa

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cells
  • Clinical Trials
  • Department Of Defense
  • Diseases And Disorders
  • Electronic Mail
  • Health Services
  • Medical Personnel
  • Neoplasms
  • New York
  • Oncology
  • Physical Properties
  • Prostate Cancer
  • Radiotherapy
  • Therapy
  • United States

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).